185 related articles for article (PubMed ID: 21905229)
1. Inhibition of aminoglycoside-deactivating enzymes APH(3')-IIIa and AAC(6')-Ii by amphiphilic paromomycin O2''-ether analogues.
Szychowski J; Kondo J; Zahr O; Auclair K; Westhof E; Hanessian S; Keillor JW
ChemMedChem; 2011 Nov; 6(11):1961-6. PubMed ID: 21905229
[TBL] [Abstract][Full Text] [Related]
2. 6-hydroxy to 6'''-amino tethered ring-to-ring macrocyclic aminoglycosides as probes for APH(3')-IIIa kinase.
Hanessian S; Szychowski J; Campos-Reales Pineda NB; Furtos A; Keillor JW
Bioorg Med Chem Lett; 2007 Jun; 17(11):3221-5. PubMed ID: 17400454
[TBL] [Abstract][Full Text] [Related]
3. N6', N6''', and O4' Modifications to Neomycin Affect Ribosomal Selectivity without Compromising Antibacterial Activity.
Sati GC; Shcherbakov D; Hobbie SN; Vasella A; Böttger EC; Crich D
ACS Infect Dis; 2017 May; 3(5):368-377. PubMed ID: 28343384
[TBL] [Abstract][Full Text] [Related]
4. Structure-guided optimization of protein kinase inhibitors reverses aminoglycoside antibiotic resistance.
Stogios PJ; Spanogiannopoulos P; Evdokimova E; Egorova O; Shakya T; Todorovic N; Capretta A; Wright GD; Savchenko A
Biochem J; 2013 Sep; 454(2):191-200. PubMed ID: 23758273
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of vertilmicin to modifications by three types of recombinant aminoglycoside-modifying enzymes.
Yuan M; Han H; Li CR; Yang XY; Li GQ; Cen S; Kang XX; Si SY; Jiang JD; You XF
Antimicrob Agents Chemother; 2011 Aug; 55(8):3950-3. PubMed ID: 21646489
[TBL] [Abstract][Full Text] [Related]
6. Identification of a small molecule inhibitor of the aminoglycoside 6'-N-acetyltransferase type Ib [AAC(6')-Ib] using mixture-based combinatorial libraries.
Tran T; Chiem K; Jani S; Arivett BA; Lin DL; Lad R; Jimenez V; Farone MB; Debevec G; Santos R; Giulianotti M; Pinilla C; Tolmasky ME
Int J Antimicrob Agents; 2018 May; 51(5):752-761. PubMed ID: 29410367
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design, synthesis, and A-site rRNA cocrystal complexes of functionally novel aminoglycoside antibiotics: C2" ether analogues of paromomycin.
Hanessian S; Szychowski J; Adhikari SS; Vasquez G; Kandasamy P; Swayze EE; Migawa MT; Ranken R; François B; Wirmer-Bartoschek J; Kondo J; Westhof E
J Med Chem; 2007 May; 50(10):2352-69. PubMed ID: 17458946
[TBL] [Abstract][Full Text] [Related]
8. Aminoglycoside resistance determinants in multiresistant
Cirit OS; Fernández-Martínez M; Yayla B; Martínez-Martínez L
Acta Microbiol Immunol Hung; 2019 Sep; 66(3):327-335. PubMed ID: 30803254
[No Abstract] [Full Text] [Related]
9. Design and synthesis of pyrankacin: a pyranmycin class of broad-spectrum aminoglycoside antibiotic.
Rai R; Chen HN; Czyryca PG; Li J; Chang CW
Org Lett; 2006 Mar; 8(5):887-9. PubMed ID: 16494466
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of APH(3')-IIIa-mediated resistance to N1-substituted aminoglycoside antibiotics.
Fong DH; Berghuis AM
Antimicrob Agents Chemother; 2009 Jul; 53(7):3049-55. PubMed ID: 19433564
[TBL] [Abstract][Full Text] [Related]
11. Assessment of 6'- and 6'''-N-acylation of aminoglycosides as a strategy to overcome bacterial resistance.
Shaul P; Green KD; Rutenberg R; Kramer M; Berkov-Zrihen Y; Breiner-Goldstein E; Garneau-Tsodikova S; Fridman M
Org Biomol Chem; 2011 Jun; 9(11):4057-63. PubMed ID: 21365081
[TBL] [Abstract][Full Text] [Related]
12. Aminoglycoside resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates from Western Norway.
Lindemann PC; Risberg K; Wiker HG; Mylvaganam H
APMIS; 2012 Jun; 120(6):495-502. PubMed ID: 22583362
[TBL] [Abstract][Full Text] [Related]
13. Amikacin potentiator activity of zinc complexed to a pyrithione derivative with enhanced solubility.
Magallon J; Vu P; Reeves C; Kwan S; Phan K; Oakley-Havens CL; Rocha K; Jimenez V; Ramirez MS; Tolmasky ME
Sci Rep; 2022 Jan; 12(1):285. PubMed ID: 34997203
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of aminoglycoside acetyltransferase resistance enzymes by metal salts.
Li Y; Green KD; Johnson BR; Garneau-Tsodikova S
Antimicrob Agents Chemother; 2015 Jul; 59(7):4148-56. PubMed ID: 25941215
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Aminoglycoside-Modifying Enzymes in Escherichia coli and Klebsiella pneumoniae Producing Extended Spectrum β-Lactamases Collected in Two Multicenter Studies in Spain.
Fernández-Martínez M; Ruiz Del Castillo B; Lecea-Cuello MJ; Rodríguez-Baño J; Pascual Á; Martínez-Martínez L;
Microb Drug Resist; 2018 May; 24(4):367-376. PubMed ID: 29727265
[TBL] [Abstract][Full Text] [Related]
16. Cloning and Expression of Novel Aminoglycoside Phosphotransferase Genes from Campylobacter and Their Role in the Resistance to Six Aminoglycosides.
Zhao S; Mukherjee S; Li C; Jones SB; Young S; McDermott PF
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109167
[TBL] [Abstract][Full Text] [Related]
17. Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes.
Cox G; Ejim L; Stogios PJ; Koteva K; Bordeleau E; Evdokimova E; Sieron AO; Savchenko A; Serio AW; Krause KM; Wright GD
ACS Infect Dis; 2018 Jun; 4(6):980-987. PubMed ID: 29634241
[TBL] [Abstract][Full Text] [Related]
18. Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia.
Okazaki A; Avison MB
Antimicrob Agents Chemother; 2007 Jan; 51(1):359-60. PubMed ID: 17088477
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of aminoglycoside antibiotic resistance enzymes by protein kinase inhibitors.
Daigle DM; McKay GA; Wright GD
J Biol Chem; 1997 Oct; 272(40):24755-8. PubMed ID: 9312069
[TBL] [Abstract][Full Text] [Related]
20. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.
Fernández-Martínez M; Miró E; Ortega A; Bou G; González-López JJ; Oliver A; Pascual A; Cercenado E; Oteo J; Martínez-Martínez L; Navarro F;
Int J Antimicrob Agents; 2015 Aug; 46(2):157-63. PubMed ID: 26022930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
